Comparative evaluation of Xpert MTB/RIF assay with multiplex polymerase chain reaction for the diagnosis of tuberculous meningitis - 15/01/19
, Megha Sharma a, 1, Lokesh Chaudhary b, Manish Modi b, 1, Manoj Goyal b, Navneet Sharma c, Aman Sharma c, Anumiti Jain b, Deba Prasad Dhibar c, Kajal Jain d, Niranjan Khandelwal e, Pallab Ray a, Vivel Lal b, Max Salfinger fAbstract |
Background |
Rapid and specific diagnosis of tuberculous meningitis (TBM) is of paramount importance to decrease morbidity and mortality. Therefore, the present study was undertaken to compare the efficacy of Xpert MTB/RIF assay (GXpert) and multiplex PCR (MPCR) using three targets (IS6110, MPB64 and protein B) for diagnosing tuberculous meningitis.
Methods |
GXpert and MPCR were performed on cerebrospinal fluid samples of 225 patients out of which 80 were culture-positive confirmed cases of TBM, 100 were ‘suspected’ cases of TBM and 45 were non-TBM controls. rpoB gene sequencing was done for diagnosing rifampicin (Rif) resistance in all positive cases.
Results |
GXpert and MPCR were positive in 91/180 (50.5%) and 157/180 (87.2%) confirmed or suspected TBM patients respectively. Both the tests were negative in all 45 controls. Rif resistance was detected in 14 cases by GXpert and in 13 cases by MPCR. Rif resistance was confirmed in 13 cases with rpoB gene sequencing. There was one case of false Rif resistance detected by GXpert which was Rif susceptible on rpoB gene sequencing. Cost of doing MPCR was less than USD1 whereas GXpert required USD10 per isolate.
Conclusion |
MPCR has a higher sensitivity than GXpert for diagnosing TBM. MPCR is a robust and cost effective method for diagnosis of TBM in low-resource and high-endemic countries.
Le texte complet de cet article est disponible en PDF.Keywords : Molecular detection tuberculous meningitis, Rifampicin resistance, IS6110, MPB64, Multiplex PCR
Plan
Vol 113
P. 38-42 - décembre 2018 Retour au numéro
Article précédent
- Characterization of specific CD4 and CD8 T-cell responses in QuantiFERON TB Gold-Plus TB1 and TB2 tubes
- Nadia PC. Allen, Gwendolyn Swarbrick, Meghan Cansler, Megan Null, Hiam Salim, Misato Miyamasu, Jenny Howard, Jeffrey Boyle, David Lewinsohn, Deborah Lewinsohn
- Validation of the FluoroType® MTBDR assay using respiratory and lymph node samples
- Carsten Haasis, Jan Rupp, Sönke Andres, Birte Schlüter, Margrit Kernbach, Doris Hillemann, Katharina Kranzer
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?